Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019.

Neural Regen Res · 2020 · PMC7047782 · PMID 31960801

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

GFAP astrogliosis was observed in both EAE groups, with a nonsignificant trend towards a decrease in the glatiramer acetate-treated group.

also in 5,406 other papers

showed a trendno p-value reported

ST266 treatment initiated at day 15 significantly prevented retinal ganglion cell loss at day 42, and treatments started on day 22 or 30 showed a trend towards increased retinal ganglion cell survival.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.